보이저 테라퓨틱스(VYGR)는 NASDAQ에 상장된 Healthcare · Biotechnology 기업입니다. 현재가 $3.06 (+0.66%), 시가총액 $0.21B, 52주 최저~최고 $2.73 ~ $5.33.
Voyager Therapeutics, Inc., a biotechnology company, focuses on the human genetics for the cure of neurological diseases. Its product pipeline includes VY1706, a tau silencing gene therapy and VY7523, an anti-tau antibody program for the treatment of alzheimer's disease. The company also provides research program for the treatment of Huntington's disease. In addition, it offers TRACER, an adeno-associated virus (AAV) capsid discovery platform; ALPL-VYGR-NeuroShuttle, to target an undisclosed neurological disease; and develops selective small molecules for the treatment of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia with TDP-43 pathology. The company has collaboration and
보이저 테라퓨틱스의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.
보이저 테라퓨틱스의 현재 주가는 $3.06 (+0.66%)입니다. BlackAll Trade에서 실시간 시세와 차트를 확인할 수 있습니다.
보이저 테라퓨틱스의 시가총액은 약 $0.21B입니다.
Voyager Therapeutics, Inc., a biotechnology company, focuses on the human genetics for the cure of neurological diseases. Its product pipeline includes VY1706, a tau silencing gene therapy and VY7523,